- Home
- AEF vs DERM Comparison
AEF vs DERM Comparison
Compare AEF & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEF
- DERM
- Stock Information
- Founded
- AEF 1989
- DERM 2014
- Country
- AEF United States
- DERM United States
- Employees
- AEF N/A
- DERM N/A
- Industry
- AEF Finance/Investors Services
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- AEF Finance
- DERM Health Care
- Exchange
- AEF Nasdaq
- DERM Nasdaq
- Market Cap
- AEF 196.1M
- DERM 174.7M
- IPO Year
- AEF N/A
- DERM 2021
- Fundamental
- Price
- AEF $5.28
- DERM $6.88
- Analyst Decision
- AEF
- DERM Strong Buy
- Analyst Count
- AEF 0
- DERM 2
- Target Price
- AEF N/A
- DERM $10.00
- AVG Volume (30 Days)
- AEF 92.5K
- DERM 80.1K
- Earning Date
- AEF 01-01-0001
- DERM 05-20-2025
- Dividend Yield
- AEF 7.13%
- DERM N/A
- EPS Growth
- AEF N/A
- DERM N/A
- EPS
- AEF 0.57
- DERM N/A
- Revenue
- AEF N/A
- DERM $56,134,000.00
- Revenue This Year
- AEF N/A
- DERM $29.83
- Revenue Next Year
- AEF N/A
- DERM $54.88
- P/E Ratio
- AEF $8.86
- DERM N/A
- Revenue Growth
- AEF N/A
- DERM N/A
- 52 Week Low
- AEF $4.40
- DERM $3.20
- 52 Week High
- AEF $5.53
- DERM $7.84
- Technical
- Relative Strength Index (RSI)
- AEF 61.21
- DERM 52.73
- Support Level
- AEF $5.20
- DERM $6.47
- Resistance Level
- AEF $5.35
- DERM $7.15
- Average True Range (ATR)
- AEF 0.07
- DERM 0.49
- MACD
- AEF 0.03
- DERM -0.09
- Stochastic Oscillator
- AEF 84.38
- DERM 37.25
About AEF abrdn Emerging Markets Equity Income Fund Inc.
ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. is a closed-end investment company. The Fund's investment objective is to seek to provide both current income and long-term capital appreciation. The Fund invests in a range of sectors, including financials, consumer staples, utilities, consumer discretionary, materials, energy, information technology, private equity, communication services, healthcare, real estate, and industrials.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.